MEDIFAST INC (MED) News

MEDIFAST INC (MED): $12.26

0.26 (+2.17%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

B

Add MED to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#7 of 7

in industry

Filter MED News Items

MED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MED News Highlights

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

  • 404 Page not found

    Error: Page not found

    The requested URL was not found on this server.

Latest MED News From Around the Web

Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.

Medifast Launches OPTAVIA ASCEND for Weight Loss Management

MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.

Yahoo | January 8, 2025

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

BALTIMORE, January 07, 2025--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle hea

Yahoo | January 7, 2025

3 Consumer Stocks to Drop Right Now

Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. The flip side is that they frequently fall behind growth industries when times are good. This trade-off has yet to emerge as the sector has posted a 10.3% return over the past six months, almost identical to the S&P 500.

Yahoo | December 19, 2024

Is Medifast, Inc.'s (NYSE:MED) Stock Price Struggling As A Result Of Its Mixed Financials?

With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the...

Yahoo | December 18, 2024

How To Use Powerful Breakaway Gaps To Buy Potentially Big Stock Market Leaders

Breakaway gaps — when a stock gaps up so strongly in price that it rises past a proper buy point — are powerful advances that can lead to more upside.

Yahoo | December 9, 2024

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

BALTIMORE, December 05, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medications and their role in health journeys, while also identifying areas where further support is necessa

Yahoo | December 5, 2024

Medifast (MED) Down 5.8% Since Last Earnings Report: Can It Rebound?

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 4, 2024

Three Reasons to Avoid MED and One Stock to Buy Instead

What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders. This may have investors wondering how to approach the situation.

Yahoo | December 3, 2024

Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3

Let’s dig into the relative performance of Nu Skin (NYSE:NUS) and its peers as we unravel the now-completed Q3 personal care earnings season.

Yahoo | December 3, 2024

Do Options Traders Know Something About Medifast (MED) Stock We Don't?

Investors need to pay close attention to Medifast (MED) stock based on the movements in the options market lately.

Yahoo | December 2, 2024


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!